Fobio
福贝生物
Fobio (福贝生物 / 4B Technologies Ltd) is a biotech company focused on central nervous system drug development, co-founded by Tsinghua neuroscientist Lu Bai and former GSK vice president Guan Xiaoming . The company has raised multiple rounds including a $25 million total through its A++ round as of early 2021, with Gaorong Ventures leading its A+ round in October 2019 and co-leading the A++ round . By January 2023 it had closed an over-100-million-yuan Pre-B round led by DCVC, with Gaorong continuing to participate . Its pipeline includes FB-1071 for ALS, which entered Phase I trials by March 2023, and FB1003 for chronic pain, which received Australian clinical approval in December 2023 . The company has also integrated AI across its R&D process, notably in its FB1006 ALS program .
AI-generated — may contain errors, please verify.
Coverage
Rongbao | Hydrogen energy and battery management tech firms secure new funding; innovative drug targets precise efficacy
Grow, toward the future.
高榕创投·Accelerated R&D and Commercialization of Frontier Products: Medical Devices, Digital Services, and New Brands Go Global | Rongbao
As the year draws to a close and a new one begins, the pace never lets up.
高榕创投·Medical Device/Chip Companies Close New Funding Rounds, Driving High-Quality Growth Through R&D, Commercialization, and Supply Chain | Rong Report · February
Infinite possibilities for creating a better life.
高榕创投·BOSS Zhipin Completes Dual Primary Listing, Baijiayun Debuts on Nasdaq, Gaorong Ventures Earns Multiple Accolades | Gaorong Monthly · December
Racing Into 2023
高榕创投·From Big Pharma to Biotech: Four Industry Leaders on How Innovative Drugs Can Balance Speed and Quality | Ronghui
Speed matters, but getting it right matters more.
高榕创投·Robotics, SaaS, and innovative drug sectors close new funding rounds; chips and medical devices unveil major new products | Rongbao · August
Differentiated innovation and global opportunities.
高榕创投·Rongbao · February | Pinduoduo Awarded "National Advanced Collective in Poverty Alleviation," Chip and Medical Companies Complete New Funding Rounds
Pinduoduo contributes to poverty alleviation; XinYaohui, Fubei Biotech, and Westlake Omics close new funding rounds.
高榕创投·Fube Biotech Closes A++ Round to Pioneer CNS Drug R&D Through Homegrown Innovation
Accelerate multiple novel neurological drug candidates into clinical trials.
高榕创投·
